Navigation Links
Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
Date:4/30/2009

arily related to changes in market conditions for certain products.

Other Operating Expenses

Consolidated general and administrative expenses for the first quarter 2009 increased $18.4 million to $68.9 million, and includes $18.0 million related to a legal settlement with Elan Corporation, PLC related to naproxen sodium.

Amortization expense for the first quarter 2009 increased $1.6 million to $21.8 million, reflecting the addition of product rights acquired from Teva Pharmaceutical Industries, Ltd.

2009 Financial Outlook

Based on actual results for the first three months of 2009 and the forecast for the remainder of the year, Watson is adjusting its estimates for the full year 2009. Watson's estimates are based on the Company's actual results for the first three months of 2009, and management's current belief about prescription trends, pricing levels, inventory levels and the anticipated timing of future product launches and events.

Watson estimates total net revenue for the full year of 2009 at approximately $2.65 billion. Estimates for segment revenue are as follows:

          -- Total Generic segment revenue between $1.50 billion and $1.60
             billion.
          -- Total Brand segment revenue between $445 million and $470
             million.
          -- Total Distribution segment revenue between $660 million and $710
             million.

Watson has increased its estimates for GAAP earnings per diluted share to between $2.15 and $2.27, and as detailed in reconciliation Table 6, adjusted earnings per diluted share is now estimated to be between $2.40 and $2.52.

Excluding special items as detailed in the EBITDA reconciliation Table 7 below, adjusted EBITDA is now estimated to be between $650 and $672 million.

Webcast and Conference Call Details

Watso
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... felt so good for "The Biggest Loser" Danny Cahill. ... to make smart choices everyday to help him stay ... that is an important part of living well. And ... of milk has nine essential nutrients like protein for ... and calcium and vitamin D for strong bones. ,, ...
(Date:12/16/2009)... 16 HealthSciences Institute will sponsor ... professionals, teams and organizations who serve individuals ... diseases in employer, health plan, medical home ... will offer free, noncommercial webinars on topics, ... prevention, management and care improvement. Each webinar ...
(Date:12/16/2009)... that could help ease health and environmental concerns about ... technology for changing the behavior of nanoparticles in municipal ... environment. Their study was published in ACS, journal ... the UK Centre for Ecology and Hydrology and colleagues ... of nanoparticles particles less than 1/1000th the width ...
(Date:12/16/2009)... but use in humans is still far off , , WEDNESDAY, ... researchers have built and tested synthetic versions of the blood-clotting ... cases where blood just won,t stop flowing. , "We start ... degradable stitches, which dissolve in the body," said Erin B. ... University, and lead author of a report published Dec. ...
(Date:12/16/2009)... for use, expert says, , , WEDNESDAY, Dec. 16 (HealthDay ... less likely to die when they receive an implantable ... included 4,685 people, ages 65 to 85, who were ... fraction (a measure of the heart,s pumping ability) of ... those who were treated with standard medication and an ...
Breaking Medicine News(10 mins):Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Behavior modification could ease concerns about nanoparticles 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:Implanted Defibrillator Might Extend Life 2
... 30 Years - Quantros President and Chief Medical Officer, Dr. Sanjaya ... importance of using technology to track and monitor data trends over ... ... Francisco, CA (PRWEB) February 17, 2009 - Quantros President and Chief ...
... Change" Campaign Part of International Effort to Combat Rare Diseases That Collectively ... ... CA (PRWEB) February 18, 2009 -- Students at Albany High School in ... some change to help support the first annual World Rare Disease Day, ...
... Feb. 18 Growth is expected in Australian ... on IT accounted for 80 percent or $258.6 million and ... For the same period, life sciences spending on IT accounted ... in the pharmaceuticals and life sciences market. It is ...
... based Renaissance Laser & Vein Institute eliminates varicose ... OAKS, Calif., Feb. 17 Southern California based ... easy and effective method for eliminating painful and ... proper vein structure is a common problem. ...
... WASHINGTON, Feb. 17 The civil rights movement ... Dakota House of Representatives voted Feb. 17 to ... http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO )Led by American Life League Associate group ... the passage of The Personhood of Children Act ...
... Medical Banking Tool Kit for,Employers, unveiled at the ... TN), is the product of a broad cross-industry ... providers, associations, health,plans, banking, government and employers predominantly ... years. , (Logo: ...
Other Medicine News:Health News:Quantros President Appears on National TV Promoting Patient Safety 2Health News:Albany High School Students Unite To Raise Awareness and Funds For World Rare Disease Day 2009 2Health News:Albany High School Students Unite To Raise Awareness and Funds For World Rare Disease Day 2009 3Health News:Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing 2Health News:Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Provides Top Notch 'Varicose Vein Treatment' 2Health News:North Dakota Personhood Bill Passes State House 51-41 2Health News:Tool Kit Helps Employers Team with Banks to Optimize Human Capital 2Health News:Tool Kit Helps Employers Team with Banks to Optimize Human Capital 3
(Date:12/16/2009)... -- CareCentrix, Inc ., the nation,s leading ... today that it has been awarded Health Utilization ... accrediting organization that establishes quality standards for the ... appropriately trained, qualified clinical personnel conduct and oversee ... timely appeals process is in place, and that ...
(Date:12/16/2009)... Inc.,today announced that it was awarded the 2009 ... New England Venture Summit, held on December 8th,at ... private companies,driving the future of innovation, was granted ... held companies that play a leading role in ... , "We are honored ...
(Date:12/16/2009)... Mich., Dec. 16 GlaxoSmithKline plc [GSK] ... today announced an exclusive licensing agreement in the ... use of NB-001, a novel, patented compound representing ... sores. Developed by NanoBio, NB-001 provides significant antimicrobial ... herpes labialis . ,, Cold sores ...
Breaking Medicine Technology:CareCentrix Receives URAC Health Utilization Management Accreditation 2Biovista Inc. Named Top Innovator in Life Sciences 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2Desert Oasis Healthcare Featured in USA Today 53913 1Desert Oasis Healthcare Featured in USA Today 53913 2Desert Oasis Healthcare Featured in USA Today 53913 3Desert Oasis Healthcare Featured in USA Today 53913 4Blue Cross Blue Shield of Michigan Michigan Attorney General and Michigan Office of Financial and Insurance Regulation Near Agreement on Rate Increas 53909 1Blue Cross Blue Shield of Michigan Michigan Attorney General and Michigan Office of Financial and Insurance Regulation Near Agreement on Rate Increas 53909 2ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 1ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 2ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 3ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 4
... a new cytokine called IL-35 could allow clinicians to,treat ... MEMPHIS, Tenn., Nov. 21 Investigators at St.,Jude ... prevents immune responses from running amok and damaging the ... treatments for cancer, using,vaccines; for autoimmune diseases, such as ...
... grounds, direct programming is superior,to cloning as a ... Nov. 20 Two major scientific,papers published this ... way to,generate patient-matched human pluripotent stem cells without ... or human or animal eggs.,Research groups in Wisconsin ...
Other Medicine Technology:St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: